NCT05402241View on ClinicalTrials.gov

IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

November 15, 2023

Study Completion Date

November 15, 2023

Conditions
Glioblastoma Multiforme
Trial Locations (2)

R3E 3P5

University of Manitoba, Winnipeg

R3A 1R9

Health Sciences Centre, Winnipeg MB

Sponsors

Collaborators (1)

CancerCare Manitoba
All Listed Sponsors
collaborator

CancerCare Manitoba

OTHER

lead

University of Manitoba

OTHER